{"id":339601,"date":"2026-11-04T18:17:40","date_gmt":"2026-11-04T12:47:40","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/sms-pharmaceuticals-q2-results-fy27-pat-40-crore\/"},"modified":"2026-11-04T18:17:40","modified_gmt":"2026-11-04T12:47:40","slug":"sms-pharmaceuticals-q2-results-fy27-pat-40-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sms-pharmaceuticals-q2-results-fy27-pat-40-crore\/","title":{"rendered":"SMS Pharmaceuticals Q2 Results FY27: Net Profit Jumps 57.45% to Rs 39.85 Cr, Revenue Rs 316.09 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

SMS Pharmaceuticals Q2 Results FY27 were declared on 4 November 2026, and the quarterly results show Consolidated revenue of Rs 316.09 Cr, up 30.38% from Rs 242.43 Cr a year earlier. Net profit rose 57.45% to Rs 39.85 Cr from Rs 25.31 Cr, while Operating Profit rose 39.91% to Rs 67.66 Cr. This YoY growth across all three lines is the main point of the filing.<\/p>\n<\/div>\n

SMS Pharmaceuticals Ltd<\/a> (SMSPHARMA) Q2 Results FY27 announced on 4 November 2026, covering the company’s financial performance for the July to September quarter. The results date brought Consolidated revenue of Rs 316.09 Cr and PAT of Rs 39.85 Cr, and SMS Pharmaceuticals Q2 Results FY27 are read here on a consolidated results basis against the same quarter last year.<\/p>\n

The results analysis of SMS Pharmaceuticals Q2 Results covers the financial highlights, the business factors, the outlook and the risks, with every figure taken from the declared filing. The Financial Highlights table below sets out revenue, Operating Profit and net profit against the same quarter last year.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n